We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02757105
Brief Title: Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)

First Submitted : April 27, 2016
First Submitted that Met QC Criteria : April 27, 2016
First Posted : April 29, 2016 (Estimate)

Results First Submitted : June 15, 2018
Results First Submitted that Met QC Criteria : July 5, 2018
Results First Posted : July 31, 2018

Last Update Submitted that Met QC Criteria : July 30, 2018
Last Update Posted : August 28, 2018